Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 4 minute read Pharma Industry News Can Merck rebuild its cardiovascular empire post-Keytruda? A closer look at its next decade of drug growth With Keytruda’s patent expiry nearing, Merck is betting on enlicitide and sotatercept to build a new cardiovascular empire. Can it succeed? byPallavi MadhirajuJune 10, 2025